A randomised, prospective study to investigate the efficacy of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linkage to halt the progression of keratoconus

British Journal of Ophthalmology

Volumn 95, Issue 11, 2011, Pages 1519-1524

  O'Brart, David P S ^a   Chan, Elsie ^a   Samaras, Konstantinos ^a   Patel, Parul ^a   Shah, Shaheen P ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CHLORAMPHENICOL; CODEINE PHOSPHATE; COLLAGEN; EYE DROPS; IBUPROFEN; LUBRICATING AGENT; OFLOXACIN; OXYBUPROCAINE; RIBOFLAVIN; TETRACAINE;

ADULT; ARTICLE; ASTIGMATISM; BEST CORRECTED VISUAL ACUITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA EROSION; CROSS LINKING; DISEASE COURSE; DRUG EFFICACY; EVENING DOSAGE; EYE PAIN; EYE REFRACTION; FEMALE; HUMAN; KERATOCONUS; KERATOMETRY; MALE; POSTOPERATIVE CARE; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFRACTION ERROR; SCAR FORMATION; SURGICAL TECHNIQUE; ULTRAVIOLET A RADIATION; UNCORRECTED VISUAL ACUITY; VISION; VISUAL ACUITY;

ADULT; COLLAGEN; CORNEA; CORNEAL TOPOGRAPHY; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; KERATOCONUS; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; TREATMENT OUTCOME; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 80054886097     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.196493     Document Type: Article

References (22)

1. Krachmer JH, Feder RS, Belin MW. Keratoconus and related non-inflammatory corneal thinning disorders. Surv Ophthalmol 1984;28:293-322. (Pubitemid 14152658)
2. Javadi MA, Motlagh BF, Jafarinasab MR, et al. Outcomes of penetrating keratoplasty in keratoconus. Cornea 2005;24:941-6. (Pubitemid 41688526)
3. Reeves SW, Stinnett S, Adelman RA, et al. Risk factors for progression to penetrating keratoplasty in patients with keratoconus. Am J Ophthalmol 2005;140:607-11.
4. Mamalis N, Anderson CW, Kreisler KR, et al. Changing trends in the indications for penetrating keratoplasty. Arch Ophthalmol 1992;110:1409-11.
5. Al-Yousef N, Marvrikakis I, Mavrikakis E, et al. Penetrating keratoplasty: indications over a 10-year period. Br J Ophthalmol 2004;88:998-1001. (Pubitemid 39013137)
6. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 2006;17:356-60. (Pubitemid 44215044)
7. Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine cornea after riboflavin/ultraviolet-A-induced crosslinking. J Cataract Refract Surg 2003;29:1780-5. (Pubitemid 37210617)
8. Spoerl E, Schreiber J, Hellmund K, et al. Untersuchungen zur Verfestigung der Hornhaut am Kaninchen. Ophthalmologe 2000;97:203-6. (Pubitemid 30190497)
9. Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res 2004;29:35-40. (Pubitemid 39389439)
10. Spoerl E, Wollensak G, Dittert DD, et al. Thermomechanical behaviour of collagen cross-linked porcine cornea. Ophthalmologica 2004;218:136-40. (Pubitemid 38338477)
11. Wollensak G, Aurich H, Pham DT, et al. Hydration behavior of porcine cornea crosslinked with riboflavin and ultraviolet A. J Cataract Refract Surg 2007;33:516-21. (Pubitemid 46281575)
12. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen cross-linking for the treatment of keratoconus. Am J Ophthalmol 2003;135:620-7. (Pubitemid 36457967)
13. Caporossi A, Baiocchi S, Mazzotta C, et al. Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study. J Cataract Refract Surg 2006;32:837-45. (Pubitemid 43831548)
14. Raiskup-Wolf F, Hoyer A, Spoerl E, et al. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg 2008;34:796-801. (Pubitemid 351615507)
15. Vinciguerra P, Albè E, Trazza S, et al. Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking. Ophthalmology 2009;116:369-78.
16. Coskunseven E, Jankov MR 2nd, Hafezi F. Contralateral eye study of corneal collagen cross-linking with riboflavin and UVA irradiation in patients with keratoconus. J Refract Surg 2009;25:371-6.
17. Wittig-Silva C, Whiting M, Lamoureux E, et al. A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results. J Refract Surg 2008;24:S720-5.
18. Mahmoud AM, Roberts CJ, Lembach RG, et al. The cone location and magnitude index. Cornea 2008;27:480-7.
19. Retzlaff J, Paden PY, Ferrell L. Vector analysis of astigmatism. J Cataract Refract Surg 1993;19:393-8.
20. Raiskup F, Hoyer A, Spoerl E. Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. J Refract Surg 2009;25:S824-8.
21. Koppen C, Vryghem JC, Gobin L, et al. Keratitis and corneal scarring after UVA/riboflavin cross-linking for keratoconus. J Refract Surg 2009;25:S819-23.
22. Pérez-Santonja JJ, Artola A, Javaloy J, et al. Microbial keratitis after corneal collagen crosslinking. J Cataract Refract Surg 2009;35:1138-40.